Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23
- PMID: 25352227
- DOI: 10.1002/biof.1186
Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23
Abstract
Body phosphate homeostasis is regulated by a hormonal counter-balanced intestine-bone-kidney axis. The major systemic hormones involved in this axis are parathyroid hormone (PTH), 1,25-dihydroxyvitamin-D, and fibroblast growth factor-23 (FGF23). FGF23, produced almost exclusively by the osteocytes, is a phosphaturic hormone that plays a major role in regulation of the bone remodeling process. Remodeling composite components, bone mineralization and resorption cycles create a continuous influx-efflux loop of the inorganic phosphate (Pi) through the skeleton. This "bone Pi loop," which is formed, is controlled by local and systemic factors according to phosphate homeostasis demands. Although FGF23 systemic actions in the kidney, and for the production of PTH and 1,25-dihydroxyvitamin-D are well established, its direct involvement in bone metabolism is currently poorly understood. This review presents the latest available evidence suggesting two aspects of FGF23 bone local activity: (a) Regulation of FGF23 production by both local and systemic factors. The suggested local factors include extracellular levels of Pi and pyrophosphate (PPi), (the Pi/PPi ratio), and another osteocyte-derived protein, sclerostin. In addition, 1,25-dihydroxyvitamin-D, synthesized locally by bone cells, may contribute to regulation of FGF23 production. The systemic control is achieved via PTH and 1,25-dihydroxyvitamin-D endocrine functions. (b) FGF23 acts as a local agent, directly affecting bone mineralization. We support the assumption that under balanced physiological conditions, sclerostin, by para- autocrine signaling, upregulates FGF23 production by the osteocyte. FGF23, in turn, acts as a mineralization inhibitor, by stimulating the generation of the major mineralization antagonist-PPi.
Keywords: FGF23; PPi; PTH; bone mineralization; extracellular Pi; sclerostin; vitamin D.
© 2014 International Union of Biochemistry and Molecular Biology.
Similar articles
-
Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis.Adv Exp Med Biol. 2012;728:65-83. doi: 10.1007/978-1-4614-0887-1_4. Adv Exp Med Biol. 2012. PMID: 22396162 Free PMC article. Review.
-
Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.Curr Opin Nephrol Hypertens. 2007 Jul;16(4):329-35. doi: 10.1097/MNH.0b013e3281ca6ffd. Curr Opin Nephrol Hypertens. 2007. PMID: 17565275 Review.
-
1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):381-8. doi: 10.1016/j.jsbmb.2006.12.054. Epub 2007 Feb 12. J Steroid Biochem Mol Biol. 2007. PMID: 17293108
-
1,25-Dihydroxyvitamin D(3) and extracellular inorganic phosphate activate mitogen-activated protein kinase pathway through fibroblast growth factor 23 contributing to hypertrophy and mineralization in osteoarthritic chondrocytes.Exp Biol Med (Maywood). 2012 Mar;237(3):241-53. doi: 10.1258/ebm.2011.011301. Epub 2012 Mar 5. Exp Biol Med (Maywood). 2012. PMID: 22393163
-
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.Bone. 2011 Oct;49(4):636-43. doi: 10.1016/j.bone.2011.06.025. Epub 2011 Jun 25. Bone. 2011. PMID: 21726676 Free PMC article.
Cited by
-
Transplantation of bone marrow-derived mesenchymal stem cells rescues partially rachitic phenotypes induced by 1,25-Dihydroxyvitamin D deficiency in mice.Am J Transl Res. 2016 Oct 15;8(10):4382-4393. eCollection 2016. Am J Transl Res. 2016. PMID: 27830022 Free PMC article.
-
Axial mechanical loading to ex vivo mouse long bone regulates endochondral ossification and endosteal mineralization through activation of the BMP-Smad pathway during postnatal growth.Bone Rep. 2021 May 7;15:101088. doi: 10.1016/j.bonr.2021.101088. eCollection 2021 Dec. Bone Rep. 2021. PMID: 34141832 Free PMC article.
-
Prenatal and Neonatal Bone Health: Updated Review on Early Identification of Newborns at High Risk for Osteopenia.Nutrients. 2023 Aug 9;15(16):3515. doi: 10.3390/nu15163515. Nutrients. 2023. PMID: 37630705 Free PMC article. Review.
-
Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement.Physiology (Bethesda). 2016 May;31(3):233-45. doi: 10.1152/physiol.00061.2014. Physiology (Bethesda). 2016. PMID: 27053737 Free PMC article. Review.
-
Marked increase in bone mineral density with oral phosphate and calcitriol in tumour-induced osteomalacia.BMJ Case Rep. 2023 Dec 6;16(12):e255355. doi: 10.1136/bcr-2023-255355. BMJ Case Rep. 2023. PMID: 38056928
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
